Please login to the form below
Asbestos
This page shows the latest Asbestos news and features for those working in and with pharma, biotech and healthcare.
J&J to FDA: there really is no asbestos in Baby Powder
as other samples from the same manufacturing lost, and has found zero asbestos. ... It was the first time that the US regulator reported finding asbestos in Johnson’s Baby Powder.
Latest news
-
Litigation concerns threaten to overshadow solid quarter at J&J
It has also been hit in the past by lawsuits involving asbestos in talc, hip replacement and vaginal mesh products, some of which are still working their way through the courts.
-
J&J found liable in first opioid mis-marketing verdict
One example is an ongoing battle over whether or not its Baby Powder product contained asbestos, where it is facing thousands of claims, including a class action of claimants saying it
-
Trump’s Brexit trade plan is bad for NHS, say campaigners
The latter could mean that products now banned because they may contain material dangerous to human health – like asbestos fibres – would be allowed to be sold in the UK, it asserts.
-
Blow for J&J as court refuses to overturn talc verdict
including its baby powder, contain asbestos and caused them to develop ovarian cancer. ... finished powders had on occasion tested positive for small amounts of asbestos “from at least 1971 to the early 2000s” and alleges the company was aware of the
-
Biotecnol taps into Cancer Research UK network for first trial
Biotecnol has already prepared the groundwork for trials in mesothelioma, an untreatable and highly-aggressive cancer which is caused by past occupational exposure to asbestos.
More from news
Approximately 1 fully matching, plus 16 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma companies to watch
Meanwhile, litigation over asbestos in talc continues, with wins and losses for the company in the last few months, with the stand-out verdict a $4.7bn damages award in Missouri ... It has had independent tests conducted on the same bottle and insists
-
The transatlantic opioid crisis
It is a situation analogous with the far reaching use and reliance upon asbestos – something promoted as a wonder material and marketed as such even after its manufacturers allegedly knew of
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
My Dad was 'one in a million', as the saying goes. But actually he was one in 300 million (of patients worldwide with rare disease)
It’s caused by inhaling asbestos fibres into the lungs and, shockingly, mesothelioma typically takes 20 to 50 years to develop! ... he contracted meso in the early 70's when working in aircraft hangers, surrounded by asbestos.
-
Rare Disease Day 2018: Five things you should know about rare diseases.
anthrax [4] and rabies [5]), or environmental factors (e.g. malignant peritoneal mesothelioma caused by asbestos exposure [6]). ... Accessed February 2018. 6. Asbestos.com. Peritoneal mesothelioma. Available at: .
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Account Director
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Sinovac’s COVID-19 vaccine appears safe in older adults
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer introduces new logo in a ‘shift from commerce to science’
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
